DUBLIN, January 18, 2022--(BUSINESS WIRE)--The "Intravenous (IV) Solutions - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Amid the COVID-19 crisis, the global market for Intravenous (IV) Solutions estimated at US$10.1 Billion in the year 2020, is projected to reach a revised size of US$15 Billion by 2026, growing at a CAGR of 6.8% over the analysis period.
Total Parenteral Nutrition, one of the segments analyzed in the report, is projected to grow at a 7.1% CAGR to reach US$11 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Peripheral Parenteral Nutrition segment is readjusted to a revised 6% CAGR for the next 7-year period.
This segment currently accounts for a 32.8% share of the global Intravenous (IV) Solutions market. Total parenteral nutrition (TPN) is an approach that involves intravenous infusion of carefully balanced blend of minerals and vitamins. The treatment is administered in life-threatening scenarios such as intestinal failure, where a patient is unable to digest and absorb essential nutrients including minerals and vitamins required for survival.
The U.S. Market is Estimated at $4.1 Billion in 2021, While China is Forecast to Reach $1.4 Billion by 2026
The Intravenous (IV) Solutions market in the U.S. is estimated at US$4.1 Billion in the year 2021. The country currently accounts for a 38.86% share in the global market. China, the world's second largest economy, is forecast to reach an estimated market size of US$1.4 Billion in the year 2026 trailing a CAGR of 8.4% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.2% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.5% CAGR while Rest of European market (as defined in the study) will reach US$684.3 Million by the end of the analysis period.
Select Competitors (Total 67 Featured):
Anhui Medipharm Co. Ltd
B. Braun Melsungen AG
Fresenius Kabi AG
ICU Medical Inc.
Wuhan Uni-Pharma Bio-Tech Co. Ltd
Key Topics Covered:
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Impact of COVID-19 Pandemic and Looming Global Recession
2020: A Year of Disruption & Transformation
As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021?
Pandemic Affects Demand for Intravenous Solutions
Elective Surgeries Report Roller-Coaster Ride Amid COVID-19, Affecting Demand for IV Solutions
COVID-19 Results in Colossal Backlog of Elective Surgeries & Extended Waiting Times
An Introduction to Intravenous (IV) Solutions
Types of Intravenous Solutions
Global Market Prospects & Outlook
TPN Emerges as the Largest Segment in the IV Solutions Market
Single Dose Amino Acid Solutions: The Major Nutrient Type
Developed Economies Lead, Developing Regions to Propel Future Growth
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Growing Prevalence of Malnutrition in Hospitalized Patients to Fuel Need for IV Solutions
Rising Prevalence of Chronic Diseases and Resultant Need for Additional Nutrition Enhances Need to Administer IV Solutions
Rising Cancer Incidence and Need for Nutritional Support
Alarming Rise in Diabetes Incidence Worldwide
Nutritional Management of Patients with Neurological Diseases
Concerns over Fluid Depletion from Body Due to GI & Diarrheal Diseases Necessitate IV Fluid Administration
Growing Numbers of Pre-term Births Drives Demand for IV Solutions
Demand Rises for Home Intravenous Nutritional Therapies
Premixed IV Nutrition: A Step towards Safer Medication Practices
Premixed Formulations Present Efficient Delivery System
Iron Replacement Therapies: Potential for Growth
Growing Demand for Low-Cost Intravenous Nutrition Solutions
COVID-19 Outbreak: Combating Medication Errors in IV Infusion
Aging Global Demography and Resultant Rise in Need for Nutrition Management Augurs Well for the Market
Increasing Healthcare Expenditure Creates Conducive Environment
Challenges Confronting IV Solutions Market
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
For more information about this report visit https://www.researchandmarkets.com/r/lurg1p
View source version on businesswire.com: https://www.businesswire.com/news/home/20220118005629/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900